Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Huma collaborates with Google Cloud to improve healthcare through generative AI

This image opens in the lightbox

News provided by

HUMA Therapeutics

29 Aug, 2023, 12:00 GMT

Share this article

Share toX

Share this article

Share toX

  • Huma aims to further support patients and the healthcare workforce by enhancing its regulated Software as Medical Device (SaMD) platform with the addition of generative AI applications
  • Huma is leveraging Google Cloud's Vertex AI platform and exploring the use of other Google GenAI tools such as Med-PaLM 2
  • Huma and Google Cloud are pursuing the safe, responsible and meaningful integration of generative AI in healthcare

NEW YORK, Aug. 29, 2023 /PRNewswire/ -- Huma Therapeutics ("Huma"), a leading global digital health company, today announced it will use Google Cloud's generative AI (GenAI) to enhance Huma's regulated disease management platform. Huma is also exploring the use of Google's GenAI tools, including Med-PaLM 2, a large language model specialised for the medical domain, to support healthcare professionals (HCPs) with better insights to optimise care delivery.

Huma's technology platform captures a range of vital signs, biomarkers and patient-reported data that are displayed on an HCP dashboard. This allows HCPs to care for many more patients than they would be able to in person, helping to alleviate workforce pressures and expand access to healthcare1. There are additional, significant efficiencies to be gained by reducing administrative tasks that take away valuable time from delivering patient-centric care and GenAI will be used to automate the generation of clinical summary reports from incoming data and surface relevant information for review in order to improve the documentation and triaging processes.

Huma's platform gathers a wealth of real-world data that hold crucial clinical insights related to disease progression, deterioration, and potential new diagnoses. However, these insights can sometimes go unnoticed. Combining GenAI with human oversight has the potential to harness the full transformative power of this data and deliver the predictive, personalised care that will greatly benefit both health systems and patients. 

GenAI will also help solve the challenge of patient engagement. Chronic disease management is intricate, and patients need support and guidance to navigate through complex treatment pathways. Yet, there is limited access to care providers. By leveraging GenAI, communication between patients and providers can be streamlined, allowing individually tailored care plans and personalised "nudges," —ultimately delivering a more delightful patient experience which can lead to improved outcomes. 

A Huma-n in the loop

Huma is well positioned to evaluate the value GenAI applications can bring to healthcare in a safe manner with a "human in the loop"— in this case, a qualified nurse or a clinician who can assess, validate, and adjust any AI outputs with appropriate guardrails in place. Huma's platform currently uses AI models to analyse patient data and provide insights that can help clinicians make better decisions.

Now, with Google Cloud's Vertex AI and other GenAI tools, Huma can develop a pipeline of use cases to make the platform even more impactful for providers and patients to drive better care delivery and outcomes.

Dan Vahdat, Huma CEO & Founder, said: "Huma is committed to making healthcare accessible and affordable for everyone and GenAI will play a crucial role in this equitable access. Our new GenAI applications will help mitigate the pressures on the healthcare workforce that exist worldwide and will reduce burnout in overworked staff. We are committed to the safe and responsible introduction of GenAI into healthcare and will ensure that Huma-ns are kept in the loop, meaning that HCPs will retain control of these health technologies."

Aashima Gupta, global director of Healthcare Strategy and Solutions, Google Cloud, said: "In a world where healthcare professionals are constantly striving to provide the best care for their patients, GenAI can be a valuable ally to lighten the load. It is not about just reducing cognitive burden; but also enhancing the personalisation of care. By incorporating AI into its disease management platform, Huma can empower its experts to focus on more complex tasks by automating repetitive ones. For example, gen AI can generate draft responses to member inquiries and requests, which Huma's experts can then review and edit as needed. This frees up Huma's experts to spend more time on tasks that require human judgement and expertise. This approach, which involves human oversight, ensures that GenAI capabilities are safe and effective."

Dr Mert Aral, Chief Medical Officer, Huma, said: "Capacity constraints, compounded by staff shortages, continue to be critical challenges across healthcare systems. As a pioneer in digital health, it is incumbent on Huma to help where it can. We are tremendously excited about this partnership and the opportunity to explore how we can harness the power of Med-PaLM 2, assessing it across different use cases to drive better triaging and care optimisation for patients. At the same time, it is paramount that these AI tools are implemented in a responsible and safe manner. Cross-sectoral collaboration will be the key to unlocking this immense potential, ushering in a new era of care delivery that is more efficient, effective and deeply Huma-n-centric."

References

1.  Po-Yin Yen et al, (2018)  Nurses' Time Allocation and Multitasking of Nursing Activities: A Time Motion Study AMIA Annu Symp Proc.: 1137–1146

About Huma

Huma Therapeutics is a global digital health technology company that advances digital-first care delivery and research to help people live longer, fuller lives. Its award-winning modular platforms are used by more than 3,000 hospitals and clinics, with over 31.5 million active users in healthcare and over 650,000 participants across research.

Huma's technology powers:

  • multi-channel patient engagement at population-wide scale for healthcare systems
  • remote patient monitoring (RPM) at scale
  • companion apps to support patients through treatment and drug therapies
  • digital clinical trials, including decentralised trials, to accelerate medical research

Huma's regulated Software as a Medical Device, used in its RPM and companion app platforms, is the only disease- and device- agnostic platform to hold EU MDR Class IIb, US FDA (510-k) Class II clearance and Class IIb registration with the UK MHRA. The SaMD platform is regulated to accept artificial intelligence algorithms and monitor patients of all ages. 
Please visit www.huma.com and follow us on LinkedIn at Huma

Logo - https://mma.prnewswire.com/media/1427908/Huma_Logo.jpg

Media contact

Karen Birmingham PhD
Head of PR & Communications, Huma
karen.birmingham@huma.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.